Nutriband appoints accomplished business leader sergei glinka to its board of directors

The glinka family invested $4.5 million into nutriband through the company's april 2024 private placement orlando, fl / accesswire / may 16, 2024 / nutriband inc. (nasdaq:ntrb)(nasdaq:ntrbw), a developer of transdermal pharmaceutical solutions, today announced the appointment of sergei glinka to its board of directors. glinka is a seasoned and highly respected business executive with an impressive track record in leadership roles across major european companies.
NTRB Ratings Summary
NTRB Quant Ranking